반응식
[NH2:1][CH2:2][C:3]1[CH:4]=[N:5][CH:6]=[CH:7][CH:8]=1.[C:9]1(=O)[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH2:18][CH2:17][CH2:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]1>>[CH:9]1([NH:1][CH2:2][C:3]2[CH:4]=[N:5][CH:6]=[CH:7][CH:8]=2)[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH2:18][CH2:17][CH2:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]1참가 물질
3
실험 절차
Following the general procedure of Example 33, but starting with 3-aminomethylpyridine and cyclopentadecanone, the title compound is produced, NMR (CDCl3, TMS) δ8.58, 7.72, 7.25, 3.76, 2.56, 1.32.
출처 및 근거
- ORD 기록
- ord-4b7dd28525f44c4fb17831940432ddbb
- 출처 데이터셋
- uspto-grants-1993_12
- 특허 번호
- US05274089
연결된 노트
불러오는 중…